Blog
Entering the Golden Era of Lateral Flow Diagnostics
BlogGold nanorods are increasingly being used in diagnostic applications, such as lateral flow assays. To learn more, we got in touch with Darren Rowles, CEO of Sona Nanotech Inc. who provides insights on diagnostic industry trends, and tells us about the source, application and production process of gold nanoparticles.
Read More
The Liquid Biopsy Trends Transforming Cancer Detection and Treatment
BlogLiquid biopsy is a less invasive approach compared to traditional surgical biopsies. By collecting a simple blood sample and analyzing circulating tumor DNA (ctDNA), cancer researchers and healthcare professionals can access a myriad of information about a patient’s tumor.
Read More
Electrophysiology Goes Digital
BlogDr Jan Dolzer, a scientist-turned-engineer that has spent his career at the leading edge of amplifier development, describes the capability of Sutter's all new digital patch clamp system
Read More
How Machine Learning Can Power Drug Discovery
BlogA recent assessment of the success of the drug development process put the percentage of phase I programs that make it to approval at 13.8%. That figure points to a crisis of attrition within the industry. Netramark, a Toronto-based start-up claim they have a machine learning-powered solution to that crisis
Read More
Sustainability Through Innovation
BlogWith growing pressure on labs to reduce waste and improve sustainability, we spoke to the Sustainability Forum at Agilent to learn more about what the company are doing to help their customers achieve their sustainability goals.
Read More
Making the Move to Continuous Bioprocessing
BlogBioprocessing has taken on many forms over the years. Efficiency and process economics are driving the bioprocessing industry forward, fueling a move from traditional stainless steel to single use – and now continuous.
Read More
Developing RNA Medicines for Rare Genetic Diseases
BlogThere are approximately 7,000 known rare diseases, however, less than 6% of these have a treatment. It is estimated that between 25–35 million Americans live with a rare disease. The company ProQR is dedicated to developing new therapeutics for patients living with untreated rare diseases. We caught up with Daniel de Boer, Chief Executive Officer at ProQR to learn more about the company’s approach to finding new treatments for rare genetic diseases.
Read More
Benefits of Using 3D Cell Models in Drug Discovery
BlogAs researchers explore therapeutic strategies for more complex and heterogeneous diseases the need for more physiologically relevant models has never been greater. Researchers are increasingly looking to 3D cell cultures, spheroids, organoids and microtissues to bridge the gap between 2D cell cultures and in vivo animal models.
Read More
Students Get Hands-on with Mass Spectrometry
BlogWe spoke to Dr Jonathan Jones from Waters Corporation, to learn more about the new initiative that they and Swansea University are leading to give students hands-on experience of mass spectrometry.
Read More
Surface Plasmon Resonance: Driving Better & Faster Decision-making in Drug Discovery
BlogWe recently spoke to Bruker’s JoAnne Bruno, Director Sales and Marketing and Sven Malik, Senior Application Specialist, to learn how surface plasmon resonance can be used to investigate the binding properties of small molecules, and how it can help researchers make better decisions about drug candidates and support efforts to design new molecules.
Read More
